Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

ABOSABOS
Showing 8 of 15 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in ACUMEN PHARMACEUTICALS INC

BANK OF AMERICA CORP /DE/ holds 274,781 shares of ABOS (ACUMEN PHARMACEUTICALS INC), worth $733,665 as of 2026-Q2. The position was decreased (-14.2% shares).

Current Value

$733,665

Current Shares

274,781

Total Value Change

+$389,629

Total Shares Change

+136,057

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
274,781
-14.2%
$733,6650.0%$2.67
0
2026-Q1
Increased
320,216
+33.3%
$755,7100.0%$2.36
32
2025-Q4
Increased
240,152
+12.4%
$506,7200.0%$2.11
18
2025-Q3
Increased
213,729
+45.4%
$365,4770.0%$1.71
22
2025-Q2
Decreased
147,009
-7.5%
$170,5300.0%$1.16
0
2025-Q1
Increased
158,934
+6.9%
$174,8270.0%$1.10
16
2024-Q4
Increased
148,668
+7.2%
$255,7090.0%$1.72
17
2024-Q3
Increased
138,724
+13.0%
$344,0360.0%$2.48
18

Other major holders of ABOS: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used